A Phase II Study to Assess the Efficacy and Safety of Olokizumab in Patients With Crohn's Disease
Clinical trial NCT01635621 · WITHDRAWN
Trial details
- NCT number
- NCT01635621
- Sponsor
- UCB BIOSCIENCES GmbH
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2013-08-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.